Related Experiment Video
Updated: Mar 23, 2026
Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
Published on: October 21, 2012
4-Nitroquinoline-1-oxide effects human lung adenocarcinoma A549 cells by regulating the expression of POLD4
Qin-Miao Huang1, Yi-Ming Zeng1, Hua-Ping Zhang1
1Department of Pulmonary Medicine, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian 362000, P.R. China.
Abstract:
The aim of the present study was to explore the expression of POLD4 in human lung adenocarcinoma A549 cells under 4-nitroquinoline-1-oxide (4NQO) stimulation to investigate the role of POLD4 in smoking-induced lung cancer. The lung cancer A549 cell line was treated with 4NQO, with or without MG132 (an inhibitor of proteasome activity), and subsequently the POLD4 level was determined by western blot analysis. Secondly, the cell sensitivity to 4NQO and Taxol was determined when the POLD4 expression level was downregulated by siRNA. The POLD4 protein levels in the A549 cells decreased following treatment with 4NQO; however, MG132 could reverse this phenotype. Downregulation of the POLD4 expression by siRNA enhanced A549 cell sensitivity to 4NQO, but not to Taxol. In conclusion, 4NQO affects human lung adenocarcinoma A549 cells by regulating the expression of POLD4.
Insights
4-nitroquinoline-1-oxide (4NQO) reduced POLD4 expression in lung cancer cells, increasing sensitivity to 4NQO. Proteasome inhibition reversed this effect, highlighting POLD4
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Lung adenocarcinoma is a major health concern, often linked to smoking.
- Understanding the molecular mechanisms of smoking-induced lung cancer is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the role of POLD4 expression in human lung adenocarcinoma A549 cells stimulated with 4-nitroquinoline-1-oxide (4NQO).
- To explore the impact of POLD4 regulation on cellular response to 4NQO and Taxol, modeling aspects of smoking-induced lung cancer.
Main Methods:
- A549 cells were treated with 4NQO, with or without MG132 (proteasome inhibitor).
- POLD4 protein levels were analyzed using western blot.
- POLD4 expression was downregulated using siRNA to assess cell sensitivity to 4NQO and Taxol.
Main Results:
- 4NQO treatment led to decreased POLD4 protein levels in A549 cells.
- MG132 treatment reversed the 4NQO-induced decrease in POLD4 levels.
- siRNA-mediated POLD4 downregulation enhanced A549 cell sensitivity to 4NQO, but not to Taxol.
Conclusions:
- 4-nitroquinoline-1-oxide (4NQO) influences human lung adenocarcinoma A549 cells by modulating POLD4 expression.
- POLD4 plays a significant role in the cellular response to 4NQO, suggesting its involvement in smoking-related lung carcinogenesis.
